Industry Briefs: October 29, 2012

Article

A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

AnGes has entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing rights of Collategene (DNA plasmid with hepatocyte growth factor gene) for treating for peripheral arterial disease in the United States. Read More

DSM Pharmaceutical Products has announced a biologics development and manufacturing agreement with Paranta Biosciences, for Paranta’s lead recombinant human protein for DSM’s at their Brisbane, Australia, facility. Read More

People News

Coldstream Laboratories has appointed Eric W. Smart as president and CEO. Read More

Eli Lilly has named Melissa Barnes as chief ethics and compliance officer, and senior vice-president. Barnes will replace Anne Nobles, following her retirement at the end of 2012. Read More

Spectrum Pharmaceuticals has appointed Joseph Turgeon as senior vice-president of sales and commercial operations. Read More

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content